Search Results

• • 4 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• The evolving management of postoperative Crohn's disease

  Authors:Jana G. Hashash and Miguel D. RegueiroFrom:Expert Review of Gastroenterology & Hepatology (Vol. 6, Issue 5) Peer-Reviewed

  Sept. 20128,891 words Report 1410LAuthor(s): Jana G Hashash [*] 1 , Miguel D Regueiro 2 Keywords : 5-aminosalicylates; 6-mercaptopurine; anti-TNF therapy; azathioprine; Crohn's disease; immunomodulator; infliximab; postoperative recurrence;...

• PUMA-mediated intestinal epithelial apoptosis contributes to ulcerative colitis in humans and mice

  Authors:Wei Qiu, Bin Wu, Xinwei Wang, Monica E. Buchanan, Miguel D. Regueiro, Douglas J. Hartman, et al.From:Journal of Clinical Investigation (Vol. 121, Issue 5) Peer-Reviewed

  May 20115,688 words Report 1430LIntestinal epithelial cell (IEC) apoptosis contributes to the development of ulcerative colitis (UC), an inflammatory bowel disease (IBD) that affects the colon and rectum. Therapies that target the inflammatory...

• The great debate: stopping immunomodulators and biologics in Crohn's disease patients in remission

  Authors:Jana G. Hashash and Miguel D. RegueiroFrom:Expert Review of Gastroenterology & Hepatology (Vol. 7, Issue 6) Peer-Reviewed

  Aug. 20131,434 words Editorial 1520LAuthor(s): Jana G Hashash 1 , Miguel D Regueiro [*] 2 Keywords : anti-TNF therapy; immunomodulator therapy; predictors of relapse Lifelong immunosuppression for Crohn's disease has been associated with...

• New research on inflammatory bowel disease

  Authors:Miguel D. Regueiro and Paul J. LebovitzFrom:Ostomy Quarterly (Vol. 35, Issue 4) Peer-Reviewed

  Summer 19981,716 words Article The basis for this article is a talk given by Paul J. Lebovitz, MD regarding new research on IBD at an Intestinal Disease Foundation educational seminar. What We Already Know An appropriate starting point for a...